Suppr超能文献

相似文献

1
Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes.
Nat Med. 2008 Jan;14(1):88-92. doi: 10.1038/nm1688. Epub 2007 Dec 9.
2
Regulating rejection with cell therapy.
Nat Biotechnol. 2008 Feb;26(2):191-2. doi: 10.1038/nbt0208-191.
4
Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells.
Eur J Immunol. 2011 Mar;41(3):726-38. doi: 10.1002/eji.201040509. Epub 2011 Jan 17.
5
Long-term prevention of chronic allograft rejection by regulatory T-cell immunotherapy involves host Foxp3-expressing T cells.
Blood. 2013 May 23;121(21):4303-10. doi: 10.1182/blood-2012-08-452037. Epub 2013 Apr 11.
7
Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.
Am J Transplant. 2008 Feb;8(2):298-306. doi: 10.1111/j.1600-6143.2007.02088.x. Epub 2008 Jan 7.
9
Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.
Transplantation. 2007 Jun 15;83(11):1449-58. doi: 10.1097/01.tp.0000265482.88936.b1.

引用本文的文献

1
Unlocking the therapeutic potential of thymus-isolated regulatory T cells.
Front Immunol. 2025 Jun 26;16:1612360. doi: 10.3389/fimmu.2025.1612360. eCollection 2025.
3
Belatacept and regulatory T cells in transplantation: synergistic strategies for immune tolerance and graft survival.
Clin Transplant Res. 2024 Dec 31;38(4):326-340. doi: 10.4285/ctr.24.0057. Epub 2024 Dec 18.
4
High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells.
Mol Ther Methods Clin Dev. 2024 Nov 18;32(4):101385. doi: 10.1016/j.omtm.2024.101385. eCollection 2024 Dec 12.
5
Few Tregs are Not Enough: Acute Rejection of Living Donor Liver Transplant.
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):102356. doi: 10.1016/j.jceh.2024.102356. Epub 2024 Jul 14.
6
Graft-Specific Regulatory T Cells for Long-Lasting, Local Tolerance Induction.
Cells. 2024 Jul 19;13(14):1216. doi: 10.3390/cells13141216.
7
Tregs in transplantation tolerance: role and therapeutic potential.
Front Transplant. 2023 Aug 30;2:1217065. doi: 10.3389/frtra.2023.1217065. eCollection 2023.

本文引用的文献

1
Clinical transplantation tolerance: many rivers to cross.
J Immunol. 2007 May 1;178(9):5419-23. doi: 10.4049/jimmunol.178.9.5419.
2
Non-myeloablative mixed chimerism approaches and tolerance, a split decision.
Eur J Immunol. 2007 May;37(5):1233-42. doi: 10.1002/eji.200636938.
3
In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.
Blood. 2007 Jan 15;109(2):827-35. doi: 10.1182/blood-2006-05-025460. Epub 2006 Sep 26.
4
Natural regulatory T cells and parasites: a common quest for host homeostasis.
Immunol Rev. 2006 Aug;212:287-300. doi: 10.1111/j.0105-2896.2006.00409.x.
5
Regulatory T cells in virus infections.
Immunol Rev. 2006 Aug;212:272-86. doi: 10.1111/j.0105-2896.2006.00412.x.
6
Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.
Immunol Rev. 2006 Aug;212:256-71. doi: 10.1111/j.0105-2896.2006.00423.x.
7
The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells.
Immunol Rev. 2006 Aug;212:60-73. doi: 10.1111/j.0105-2896.2006.00415.x.
8
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Immunol Rev. 2006 Aug;212:8-27. doi: 10.1111/j.0105-2896.2006.00427.x.
9
Regulatory T cells in cancer.
Blood. 2006 Aug 1;108(3):804-11. doi: 10.1182/blood-2006-02-002774.
10
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.
Am J Transplant. 2006 Sep;6(9):2121-33. doi: 10.1111/j.1600-6143.2006.01434.x. Epub 2006 Jun 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验